Pfizer hopes to have results from its late-stage clinical trial for its coronavirus vaccine by October. There are 23,000 individuals enrolled in Phase III of the trial which began in July. (CNBC)
Meanwhile, hamsters injected with Johnson & Johnsons’ COVID-19 vaccine did not suffer severe illness such as pneumonia. The drugmaker plans to begin Phase III trials in September. (Reuters)
Amarin has lost its appeal for Vascepa patent. The drugmaker’s heart drug may now face generic competition from companies such as Hikma Pharmaceuticals and Dr. Reddy’s Laboratories. (STAT)
A coronavirus vaccine decision will not be made based on politics, according to Dr. Anthony Fauci, White House coronavirus advisor. Fauci said any decision will be made based on clinical trial results and will be reviewed by the Data and Safety Monitoring Board. (CNBC)
Where does your company rank? There’s still time to submit your company’s questionnaire to MM+M’s 2020 Best Places to Work. Entries close on September 11. (MM+M)
